Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4-5
pubmed:dateCreated
1999-12-22
pubmed:abstractText
DNA or nucleic acid immunization has been shown to induce both antigen-specific cellular and humoral immune responses in vivo. Moreover, immune responses induced by DNA immunization can be enhanced and modulated by the use of molecular adjuvants. To engineer the immune response in vivo towards more T-helper (Th)1-type cellular responses, we investigated the co-delivery of inteferon (IFN)-gamma, interleukin (IL)-12, and IL-18 genes along with DNA vaccine constructs. We observed that both antigen-specific humoral and cellular immune responses can be modulated through the use of cytokine adjuvants in mice. Most of this work has been performed in rodent models. There has been little confirmation of this technology in primates. We also evaluated the immunomodulatory effects of this approach in rhesus macaques, since non-human primates represent the most relevant animal models for human immunodeficiency virus (HIV) vaccine studies. As in the murine studies, we also observed that each Th1 cytokine adjuvant distinctively regulated the level of immune responses generated. Co-immunization of IFN-gamma and IL-18 in macaques enhanced the level of antigen-specific antibody responses. Similarly, co-delivery of IL-12 and IL-18 also enhanced the level of antigen-specific Th proliferative responses. These results extend this adjuvant strategy in a more relevant primate model and support the potential utility of these molecular adjuvants in DNA vaccine regimens.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0047-2565
pubmed:author
pubmed:issnType
Print
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
214-23
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:10593488-AIDS Vaccines, pubmed-meshheading:10593488-Adjuvants, Immunologic, pubmed-meshheading:10593488-Animals, pubmed-meshheading:10593488-Antibody Formation, pubmed-meshheading:10593488-Antigen-Antibody Reactions, pubmed-meshheading:10593488-Disease Models, Animal, pubmed-meshheading:10593488-Female, pubmed-meshheading:10593488-HIV Infections, pubmed-meshheading:10593488-Immunity, Cellular, pubmed-meshheading:10593488-Immunization, pubmed-meshheading:10593488-Interleukin-12, pubmed-meshheading:10593488-Interleukin-18, pubmed-meshheading:10593488-Macaca mulatta, pubmed-meshheading:10593488-Mice, pubmed-meshheading:10593488-Mice, Inbred BALB C, pubmed-meshheading:10593488-Simian immunodeficiency virus, pubmed-meshheading:10593488-T-Lymphocytes, Helper-Inducer, pubmed-meshheading:10593488-Vaccines, DNA
pubmed:articleTitle
Antigen-specific humoral and cellular immune responses can be modulated in rhesus macaques through the use of IFN-gamma, IL-12, or IL-18 gene adjuvants.
pubmed:affiliation
Department of Pathology, University of Pennsylvania, Philadelphia 19104, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.